Member Info for Enki

Billy may the £1 party come soon. Looking forward to you throwing a party and meeting some lth when it happens.

Love to put a face to Coblat and Potnak. I already have my suspicions Parker is SOG.

Good luck to you Billy and us all. £1 is the starter.

SaintNick, readers may also recollect the TR1 by The Royal Bank of Canada in Sept 2021 when by dilution they dropped below 5% to c4.99%. We never got one after that as there was no requirement. I wonder if they saw the writing on the wall and quietly sold out on the spikes too.

Likewise HSBC and that wealthy South African individual, James Goezee who was gushing on twitter about our beloved copl.

Did they all lose too?

Those 3,742,391 shares say at cost of c21p to the ii is only c£800k in monetary terms. Of the £3.36 Million raised , it would be highly plausible that an ii has taken a declarable stake. About time we had this type of investor aboard.

Muldoon, don't forget Angra is going great guns and Semnet may land another deal or too. So we should all be in for a pleasant surprise.

As a sidenote thank goodness for a return to a reasonable readable board. We want to attract knowledgeable posters not revile them.

The TVR is now 124,746,338. So the 3% level is 3,742,391. With all the big trades recently, could we see an TR1 next week too?

Just to saying the best in class , wonderful science etc doesn't cut it anymore. If it truly is that good why has a deal not been done up to now?

At this rate with the advances in AI small molecule design and discovery may put us in the has been class.

Massive, keep the faith. I think the next 2 months is going to blow us out of the water.

I'm hoping to buy more in too before it really kicks off.

Sorry adult onset dyslexia.....buys

They must be busy in all probability as the price is on the up.

I keep going on about a TR1 but this ii must be over 3% by now , unless of course they are overseas

4p by end of October, child gets your fingers put of your eyes.

Muldoon more will follow. This is just warming up.

Potnak, whatever questions are asked we will be faced by a smug Parker and Mutchell. They are fully funded and their wages paid for at least a couple of years. Let's hope they don't apply to MHRA again for the further investigations.

If they have anything to say they should answer simple uncomplicated questions about the future. eg when is the timetable for the extra tox data needed going to be published and as you say will they actually stick to anything.

I do take comfort from the financial position however we achieved it. This should filter out to investors and industry alike. Edison should be worth a look at later in the month.

Even they have had a lie in this am. Lets see thoe 1 and 2 share trades , I dare you.

Good on you shepherd, it's a good time to get in. I think those waiting for sub 20p are going to be disappointed.

Nobody is being fooled into selling here. The BoD needs to get into gear and publish a plan going forward.

In the interim 737 news should cheer us up because at last it may be taken into P3.

Sorry blowdog, understood. Maybe today could be Massive or Wellesley Friday.

Blowdog, I believe that the semnet deal and share issue is already built into the current sp at aroundc 0.7 ish.

It makes semse to hold for a potential spike on further updates eg Bonfirepay and perhaps other news pre-results in Deecmebr.

Father Ted, precisely the change in agenda to suddenly 1802 tox as well as further 1801 investigation to me shows a seep inbult scientific arrogance at the expence of investors.

I am beginning to suspect SOG is lady penelope to Parker. I like a lot of lth want out , instead we have continued the gravy train for now hopefully to some sort of conclusion. The good thing is we are now all well versed and not catch out any new investors.

Parker we know your score, no doubt he'll use AI answers that give no substance and read out verbatim , so same old year in year out.

An answer from the agm last year for refreshment. Question 10:

"Assuming the Board has a strategy in place for the commercialisation of SDC-1801, could you outline some of the factors taken into consideration during the planning?

Our Board has conducted market research to identify which companies are most likely to consider in-licensing a product such as SDC-1801 and to understand the strengths and weaknesses of our competitors. We also have a continued dialogue with potential partners to understand what they need to see in a data package before committing to a licensing deal.nswer."

Begs the question why the extra tox studies if they had known all along?

John , are you still invested? I remember your daily 4am posts and sense of humour at other times.